Haute 100 San Francisco Update: Anne Wojcicki & Sergey Brin

Our Haute 100 list details the accomplishments of the most influential people in each of our markets—MiamiNew YorkLos Angeles, and San Francisco. These people continue to make moves, so rather than waiting for the next Haute 100 issue to come out, we thought we’d provide you with regular updates on those Haute 100 members who are making headlines. Check back daily for more info on the most powerful people in your city. Co-founded by CEO Anne Wojcicki, 23andMe, Inc. has closed its Series C round with over $22 million, raised in part by spouse Sergey Brin’s Google Ventures.

Anne Wojcicki & Sergey Brin

Category: Power Couples

Company: 23andMe & Google

Industry: Personal Genetics & Technology

What Made Them Haute: He’s a co-founder of Google—need we say more? She partnered with Linda Avery to found 23andMe, a company that profiles personal genetics to help determine the role that genes play in everyone’s lives with a goal of creating personalized medicine. Google provided a bit of the start-up capital for this venture.

What Makes Them Haute Now: 23andMe Inc. is all about you, well, you and your paired chromosomes, that is. The personal genetics company, dedicated to helping individuals understand their own genetic information through DNA analysis technologies and Web-based interactive tools, co-founded by Anne Wojcicki has raised more than $22 million in Series C financing. Johnson & Johnson Development Corp. and current investors New Enterprise Associates and Google Ventures led the third round of funding. “We believe this round of financing will help us achieve our goal of dramatically accelerating the pace of research and could ultimately make health care research and health care delivery more efficient,” Wojcicki says. The Mountain View-based company has garnered more than $44 million in funding since its start up in April 2006.

Like Haute Living San Francisco? Join our Facebook page. Want Haute Living San Francisco delivered to your in box once a week? Sign up for our newsletter.